Prognostic Value of Fibrinogen-to-Albumin Ratio in Coronary Three-Vessel Disease

References

• Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circ Res. 2019;124(2):315–327. doi:10.1161/CIRCRESAHA.118.313591
   PubMed Web of Science ®Google Scholar
• Head SJ, Milojevic M, Daemen J, et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet. 2018;391(10124):939–948. doi:10.1016/S0140-6736(18)30423-9
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhu Y, Wang J, et al. Gender-based long-term outcomes after revascularization for three-vessel coronary disease: a propensity score-matched analysis of a large cohort. Clin Interv Aging. 2022;17:545–554. doi:10.2147/CIA.S362027
   PubMed Web of Science ®Google Scholar
• Guo L, Lv H, Wang J, et al. Predictive value of high sensitivity C-reactive protein in three-vessel disease patients with and without type 2 diabetes. Cardiovasc Diabetol. 2023;22(1):91. doi:10.1186/s12933-023-01830-7
   PubMed Web of Science ®Google Scholar
• Papageorgiou N, Tousoulis D, Siasos G, et al. Is fibrinogen a marker of inflammation in coronary artery disease? Hellenic J Cardiol. 2010;51(1):1–9.
   PubMed Web of Science ®Google Scholar
• Peng Y, Wang H, Li YM, et al. Relation between admission plasma fibrinogen levels and mortality in Chinese patients with coronary artery disease. Sci Rep. 2016;6(1):30506.
   PubMedGoogle Scholar
• Roche M, Rondeau P, Singh NR, et al. The antioxidant properties of serum albumin. FEBS Lett. 2008;582(13):1783–1787. doi:10.1016/j.febslet.2008.04.057
   PubMed Web of Science ®Google Scholar
• Plakht Y, Gilutz H, Shiyovich A. Decreased admission serum albumin level is an independent predictor of long-term mortality in hospital survivors of acute myocardial infarction. Soroka Acute Myocardial Infarction II (SAMI-II) project. Int J Cardiol. 2016;219:20–24. doi:10.1016/j.ijcard.2016.05.067
   PubMed Web of Science ®Google Scholar
• Tan Z, Zhang M, Han Q, et al. A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the Fibrinogen/Albumin Ratio. J Cancer. 2017;8(6):1025–1029. doi:10.7150/jca.16491
   PubMed Web of Science ®Google Scholar
• Wu W, Wang Q, Han D, et al. Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection. Cancer Cell Int. 2021;21(1):500. doi:10.1186/s12935-021-02204-3
   PubMed Web of Science ®Google Scholar
• Yang Q, Liang D, Yu Y, et al. The prognostic significance of the fibrinogen-to-albumin ratio in patients with triple-negative breast cancer: a retrospective study. Front Surg. 2022;9:916298. doi:10.3389/fsurg.2022.916298
   PubMed Web of Science ®Google Scholar
• Li M, Tang C, Luo E, et al. Relation of fibrinogen-to-albumin ratio to severity of coronary artery disease and long-term prognosis in patients with Non-ST elevation acute coronary syndrome. Biomed Res Int. 2020;2020:1–10.
   Web of Science ®Google Scholar
• Hou XG, Wu TT, Zheng YY, et al. The fibrinogen-to-albumin ratio is associated with poor prognosis in patients with coronary artery disease: findings from a large cohort. J Cardiovasc Transl Res. 2023;16(5):1177–1183. doi:10.1007/s12265-023-10402-9
   PubMed Web of Science ®Google Scholar
• Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596–e646. doi:10.1161/CIR.0000000000000678
   PubMed Web of Science ®Google Scholar
• Guo L, Zhong L, Chen K, et al. Long-term clinical outcomes of optimal medical therapy vs. successful percutaneous coronary intervention for patients with coronary chronic total occlusions. Hellenic J Cardiol. 2018;59(5):281–287. doi:10.1016/j.hjc.2018.03.005
   PubMed Web of Science ®Google Scholar
• Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336(14):973–979. doi:10.1056/NEJM199704033361401
   PubMed Web of Science ®Google Scholar
• Kryczka KE, Kruk M, Demkow M, et al. Fibrinogen and a triad of thrombosis, inflammation, and the renin-angiotensin system in premature coronary artery disease in women: a new insight into sex-related differences in the pathogenesis of the disease. Biomolecules. 2021;11(7):1036. doi:10.3390/biom11071036
   PubMed Web of Science ®Google Scholar
• Jensen T, Kierulf P, Sandset PM, et al. Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells. Thromb Haemost. 2007;97(5):822–829. doi:10.1160/TH07-01-0039
   PubMed Web of Science ®Google Scholar
• Induruwa I, Moroi M, Bonna A, et al. Platelet collagen receptor Glycoprotein VI-dimer recognizes fibrinogen and fibrin through their D-domains, contributing to platelet adhesion and activation during thrombus formation. J Thromb Haemost. 2018;16(2):389–404. doi:10.1111/jth.13919
   PubMed Web of Science ®Google Scholar
• Shi Y, Wu Y, Bian C, et al. Predictive value of plasma fibrinogen levels in patients admitted for acute coronary syndrome. Tex Heart Inst J. 2010;37(2):178–183.
   PubMed Web of Science ®Google Scholar
• Prajapati KD, Sharma SS, Roy N. Current perspectives on potential role of albumin in neuroprotection. Rev Neurosci. 2011;22(3):355–363. doi:10.1515/rns.2011.028
   PubMed Web of Science ®Google Scholar
• Arques S. Human serum albumin in cardiovascular diseases. Eur J Intern Med. 2018;52:8–12. doi:10.1016/j.ejim.2018.04.014
   PubMed Web of Science ®Google Scholar
• Batta A, Sharma YP, Hatwal J, et al. Predictors of dementia amongst newly diagnosed non-valvular atrial fibrillation patients. Indian Heart J. 2022;74(6):505–509. doi:10.1016/j.ihj.2022.11.009
   PubMedGoogle Scholar
• Ozkan E, Elcik D, Barutcu S, et al. Inflammatory markers as predictors of atrial fibrillation recurrence: exploring the C-reactive protein to albumin ratio in cryoablation patients. J Clin Med. 2023;12(19):6313. doi:10.3390/jcm12196313
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yang J, Ji Y, et al. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Heart Vessels. 2019;34(10):1600–1607. doi:10.1007/s00380-019-01399-w
   PubMed Web of Science ®Google Scholar
• Liu G, Fan C-M, Guo H, et al. Fibrinogen‑to‑albumin ratio predicts long‑term outcomes for patients with ST‑elevation myocardial infarction and multivessel disease: a prospective observational cohort study. Exp Ther Med. 2021;21(5):465. doi:10.3892/etm.2021.9896
   PubMed Web of Science ®Google Scholar
• Makkar K, Sharma YP, Batta A, et al. Role of fibrinogen, albumin and fibrinogen to albumin ratio in determining angiographic severity and outcomes in acute coronary syndrome. World J Cardiol. 2023;15(1):13–22. doi:10.4330/wjc.v15.i1.13
   PubMed Web of Science ®Google Scholar
• Karahan O, Acet H, Ertaş F, et al. The relationship between fibrinogen to albumin ratio and severity of coronary artery disease in patients with STEMI. Am J Emerg Med. 2016;34(6):1037–1042. doi:10.1016/j.ajem.2016.03.003
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–1131. doi:10.1056/NEJMoa1707914
   PubMed Web of Science ®Google Scholar
• Jiménez JJ, Iribarren JL, Brouard M, et al. Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, Phase IV clinical trial. J Cardiothorac Surg. 2011;6(1):138. doi:10.1186/1749-8090-6-138
   PubMedGoogle Scholar